BOA Orthopaedic Surgery Research Centre

The BOA Orthopaedic Surgery Research Centre (BOSRC), based at York Trials Unit, supports the BOA in expanding the number of trials in the UK related to Trauma and Orthopaedics. The activity by the research team at York over the past year (July 2015-June 2016) is summarised here:

New research

Four new research studies are now underway following successful grant applications.  One study, known as the OPAL study, will develop an occupational advice intervention to support early recovery to usual activities including work, for patients undergoing hip and knee replacements. The second project underway is investigating the topic of how best to manage rib fractures.

The third study will investigate whether a collagenase injection is as good as surgery at treating Dupuytren’s contracture. If the injection is found to be as good as surgery it means that patients can have an alternative option to surgery. The fourth study will address the problem of knee swelling following total knee replacement, which is a common problem for patients.

The BOSRC initiative has so far secured more than £2.7million of funding for trauma and orthopaedic research.

New grant applications

In the past year, grant applications have been submitted for six different research projects with surgeons from across the country and the outcomes are pending.

Engagement and networking activities

The research team contributed to eight events attended by Trauma and Orthopaedic surgeons to inform them about research methods and making applications for research funding.

Submit your research idea!

The BOSRC will provide methodological support and grant-writing advice to orthopaedic surgeons in order to develop their research idea into a fundable proposal. Not all ideas may come to fruition, but if you do have an idea you wish to explore, please complete the form available here (Accessing support from BOA tab) and email it to the BOSRC.

Upcoming Events

Undertaking Clinical Trials in Trauma and Orthopaedics - 20-21 November 2017

Supported by